Using 2013 data from state prescription drug monitoring programs from eight states, the CDC found that prescribing practices between states vary drastically.
With an estimated 60 million people in the United States experiencing heartburn at least once a month, and more than 15 million suffering from it daily, products to treat the condition have become more sophisticated, and the battle for supremacy in the $2.18 billion-a-year antacid tablets market has grown more heated.
The New York Times outlines the controversy surrounding the recent FDA approval of Oxycontin in children. “Just because OxyContin has been abused or prescribed inappropriately doesn’t mean we should deprive the children who need the drug,” Kathleen Neville, pediatric oncologist at Arkansas Children's Hospital told The New York Times, adding it is “our obligation to have the best level of evidence for its use in children.” (The New York Times)
According to CBS Miami, the Florida Board of Pharmacy has adopted a rule change that looks to help pharmacists ensure that patients who need prescribed controlled substances can get them. “Instead of starting out with trying to find a reason to doubt a prescription, you start off with an assumption that everything in the prescription is good, and you work towards achieving patient access,” Florida Pharmacy Association EVP Michael Jackson said. (CBS Miami)
More than 80% of Americans support medical school and physician residency programs to provide training for physicians in how to treat chronic pain and how to detect and treat addiction to prescription pain medication.
The pharmaceutical company is donating thousands of its Evzio auto-injectors ahead of a planned Oct. 4 Washington, D.C. rally for recognizing and treating opioid addiction.
CVS/pharmacy has also renewed its Medication Disposal for Safer Communities Program.
The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works.
U.S. Pain Foundation founder and president Paul Gileno duscusses his personal connection to chronic pain and the importance of focusing on pain management — particularly during September, Pain Awareness Month.